Search PubMed⌕ Search

Biomedical subjects

Edward W Johnson

Publications and source records attributed to Edward W Johnson.

2 recordsLinked to original sources

Morphological characteristics of the vomeronasal organ of the newborn Asian elephant (Elephas maximus).

The 6-week-old Asian elephant (Elephas maximus) has a well-documented precocious flehmen response to pheromones, suggesting that the pheromone-detecting vomeronasal organ (VNO) is functional very early in the life of this species. To further document this, the VNOs of two newborn elephants were examined in situ and analyzed by light microscopy (LM) to ascertain their structural maturity at birth. A tubular, cartilage-encased VNO was located along the anterior base of each side of the nasal septum. Its rostral end was connected to a duct to the roof of the mouth; the caudal end was attached to a well-defined vomeronasal nerve projecting toward the brain. LM revealed distinctive differences in the mucosae bordering the horseshoe-shaped lumen: a concave, sensory mucosa, and a convex, nonsensory mucosa. Small groups of receptor neurons were observed among ciliated columnar cells in the sensory epithelium. Numerous unmyelinated nerve bundles and blood vessels filled the underlying lamina propria (LP) and a small section of the vomeronasal nerve was conspicuous at one edge. The nonsensory mucosa manifested a thinner epithelium that principally consisted of ciliated columnar cells, some of which showed a granular cytoplasm, and a conspicuous row of basal cells. The LP was replete with acinar glands and ducts that opened into the lumen. This study shows that the VNO of the newborn elephant has reached an advanced stage of structural maturity, closely resembling that of the adult. Its composition supports the view that flehmen at 6 weeks delivers pheromones to a functional VNO.

Animals↗

Early use of recombinant factor VIIa improves mean arterial pressure and may potentially decrease mortality in experimental hemorrhagic shock: a pilot study.

BACKGROUND: Recombinant factor VIIa (rFVIIa) is used for treatment of bleeding episodes in hemophilia patients who develop inhibitors to factors VIII and IX. We tested the hypothesis that administration of rFVIIa early after injury would decrease bleeding and improve survival after experimental hepatic trauma. METHODS: Anesthetized swine were cannulated for blood sampling and hemodynamic monitoring. Avulsion of left median lobe of the liver induced uncontrolled hemorrhage. After a 10% reduction of mean arterial pressure, animals were blindly randomized to receive intravenous rFVIIa (180 microg/kg) (n = 6) or placebo (n = 7). RESULTS: Mortality was 43% (three of seven) in controls versus 0% with rFVIIa (p = 0.08, chi2). Significantly shorter prothrombin time and higher mean arterial pressures were observed in the rFVIIa group. CONCLUSION: Intravenous administration of rFVIIa early after induction of hemorrhage shortens prothrombin time and improves mean arterial pressure. A trend toward improved survival was observed.

Animals↗